Acer Therapeutics Inc (NASDAQ:ACER) Sellers Declined By 17.49% Their Shorts As Of Apr 17, 2018

April 17, 2018 - By Joseph Norton

Change of 17.49% for Acer Therapeutics Inc (NASDAQ:ACER)’s shares shorted was showed. It was published in April by FINRA the 15,100 shares shorted on ACER. Previously was reported down change of 17.49% from 18,300 shares. 1 days will cost ACER With 19,300 average volume to recover its former position.

The stock increased 1.14% or $0.22 during the last trading session, reaching $19.49.Acer Therapeutics Inc. has volume of 8,775 shares. Since April 17, 2017 ACER has risen 126.38% and is uptrending. The stock outperformed the S&P500 by 114.83%.

Acer Therapeutics Inc. develops therapies for the treatment of serious ultra-rare diseases with critical unmet medical needs.The company has $146.13 million market cap. The firm offers Celiprolol for vascular ehlers-danlos syndrome and ACER-001 for maple syrup urine disease .Last it reported negative earnings. It also offers advancing ACER-001 for the treatment of urea cycle disorders (UCD).

Acer Therapeutics Inc. (NASDAQ:ACER) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: